The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs - PubMed (original) (raw)
- PMID: 5954044
The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs
J M van Rossum. Arch Int Pharmacodyn Ther. 1966 Apr.
No abstract available
Similar articles
- [Action and mechanism of action of catecholamines and their derivatives].
Ariëns EJ. Ariëns EJ. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967;257(1):118-41. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967. PMID: 4385328 German. No abstract available. - Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.
Iversen LL, Rogawski MA, Miller RJ. Iversen LL, et al. Mol Pharmacol. 1976 Mar;12(2):251-62. Mol Pharmacol. 1976. PMID: 4724 No abstract available. - [Psychopharmacological aspects of emotional stress].
Val'dman AV. Val'dman AV. Vestn Akad Med Nauk SSSR. 1975;(8):26-33. Vestn Akad Med Nauk SSSR. 1975. PMID: 240241 Russian. No abstract available. - Two types of dopamine receptors in behavioral regulation.
van Rossum JM. van Rossum JM. Fed Proc. 1978 Aug;37(10):2415-21. Fed Proc. 1978. PMID: 354975 Review.
Cited by
- Schizophrenia genomics: genetic complexity and functional insights.
Sullivan PF, Yao S, Hjerling-Leffler J. Sullivan PF, et al. Nat Rev Neurosci. 2024 Sep;25(9):611-624. doi: 10.1038/s41583-024-00837-7. Epub 2024 Jul 19. Nat Rev Neurosci. 2024. PMID: 39030273 Review. - The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review.
Bononi G, Lonzi C, Tuccinardi T, Minutolo F, Granchi C. Bononi G, et al. Molecules. 2024 Apr 23;29(9):1930. doi: 10.3390/molecules29091930. Molecules. 2024. PMID: 38731421 Free PMC article. Review. - CREB: A Promising Therapeutic Target for Treating Psychiatric Disorders.
Guan W, Ni MX, Gu HJ, Yang Y. Guan W, et al. Curr Neuropharmacol. 2024;22(14):2384-2401. doi: 10.2174/1570159X22666240206111838. Curr Neuropharmacol. 2024. PMID: 38372284 Review. - Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study.
Lombardozzi G, Trovini G, Amici E, Kotzalidis GD, Perrini F, Giovanetti V, Di Giovanni A, De Filippis S. Lombardozzi G, et al. Front Psychiatry. 2023 Dec 4;14:1321233. doi: 10.3389/fpsyt.2023.1321233. eCollection 2023. Front Psychiatry. 2023. PMID: 38111619 Free PMC article. - Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia.
Vinnakota C, Hudson MR, Jones NC, Sundram S, Hill RA. Vinnakota C, et al. Int J Mol Sci. 2023 Jul 23;24(14):11835. doi: 10.3390/ijms241411835. Int J Mol Sci. 2023. PMID: 37511595 Free PMC article. Review.